Literature DB >> 5286444

L-asparaginase therapy in children with advanced leukemia. The Southwest Cancer Chemotherapy Study Group.

W W Sutow, F Garcia, K A Starling, T E Williams, D M Lane, E A Gehan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5286444     DOI： 10.1002/1097-0142(1971)28:4<819::aid-cncr2820280403>3.0.co;2-9

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  11 in total

Review 1.  Asparagine synthetase chemotherapy.

Authors:  Nigel G J Richards; Michael S Kilberg
Journal:  Annu Rev Biochem       Date:  2006       Impact factor: 23.643

2.  An inhibitor of human asparagine synthetase suppresses proliferation of an L-asparaginase-resistant leukemia cell line.

Authors:  Jemy A Gutierrez; Yuan-Xiang Pan; Lukasz Koroniak; Jun Hiratake; Michael S Kilberg; Nigel G J Richards
Journal:  Chem Biol       Date:  2006-12

3.  Asparagine synthetase expression alone is sufficient to induce l-asparaginase resistance in MOLT-4 human leukaemia cells.

Authors:  A M Aslanian; B S Fletcher; M S Kilberg
Journal:  Biochem J       Date:  2001-07-01       Impact factor: 3.857

Review 4.  Drugging cancer metabolism: Expectations vs. reality.

Authors:  David C Montrose; Lorenzo Galluzzi
Journal:  Int Rev Cell Mol Biol       Date:  2019-07-29       Impact factor: 6.813

5.  Erwinia asparaginase achieves therapeutic activity after pegaspargase allergy: a report from the Children's Oncology Group.

Authors:  Wanda L Salzer; Barbara Asselin; Jeffrey G Supko; Meenakshi Devidas; Nicole A Kaiser; Paul Plourde; Naomi J Winick; Gregory H Reaman; Elizabeth Raetz; William L Carroll; Stephen P Hunger
Journal:  Blood       Date:  2013-06-05       Impact factor: 22.113

6.  Multiple adaptive mechanisms affect asparagine synthetase substrate availability in asparaginase-resistant MOLT-4 human leukaemia cells.

Authors:  A M Aslanian; M S Kilberg
Journal:  Biochem J       Date:  2001-08-15       Impact factor: 3.857

7.  Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase.

Authors:  Shotaro Iwamoto; Keichiro Mihara; James R Downing; Ching-Hon Pui; Dario Campana
Journal:  J Clin Invest       Date:  2007-03-22       Impact factor: 14.808

8.  Deficiency in asparagine synthetase expression in rectal cancers receiving concurrent chemoradiotherapy: negative prognostic impact and therapeutic relevance.

Authors:  Ching-Yih Lin; Ming-Jen Sheu; Chien-Feng Li; Sung-Wei Lee; Li-Ching Lin; Yi-Fong Wang; Shang-Hung Chen
Journal:  Tumour Biol       Date:  2014-04-13

9.  Thiol-maleimide poly(ethylene glycol) crosslinking of L-asparaginase subunits at recombinant cysteine residues introduced by mutagenesis.

Authors:  Josell Ramirez-Paz; Manoj Saxena; Louis J Delinois; Freisa M Joaquín-Ovalle; Shiru Lin; Zhongfang Chen; Virginia A Rojas-Nieves; Kai Griebenow
Journal:  PLoS One       Date:  2018-07-27       Impact factor: 3.240

Review 10.  L-asparaginase in the treatment of patients with acute lymphoblastic leukemia.

Authors:  Rachel A Egler; Sanjay P Ahuja; Yousif Matloub
Journal:  J Pharmacol Pharmacother       Date:  2016 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.